Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study.
Albani A, Ferraù F, Ciresi A, Pivonello R, Scaroni C, Iacuaniello D, Zilio M, Guarnotta V, Alibrandi A, Messina E, Boscaro M, Giordano C, Colao A, Cannavo S.
Albani A, et al. Among authors: pivonello r.
Endocrine. 2018 Jul;61(1):118-124. doi: 10.1007/s12020-018-1524-5. Epub 2018 Jan 30.
Endocrine. 2018.
PMID: 29383677